SCHEMBL24960723

SCHEMBL24960723

CC(C)c1ccc2c(c1)c1cc(C(C)(C)C)cc3c4cc5c6ccccc6c6cc7c8cc(C(C)(C)C)cc9c%10cc(C(C)(C)C)ccc%10n(c7cc6c5cc4n2c13)c98

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORA P35398 3/20 0.39
RORC P51449 3/20 0.39
RORB Q92753 3/20 0.39
PGR P06401 2/20 0.38
KIF11 P52732 3/20 0.35
DNMT1 P26358 3/20 0.33
HTR1D P28221 1/20 0.33
PTGES2 Q9H7Z7 2/20 0.32
NR1H3 Q13133 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
PLA2G1B P04054 1/20 0.31
NFKB1 P19838 1/20 0.31
CASP3 P42574 1/20 0.31
RAB9A P51151 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
SENP8 Q96LD8 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20857985 0.89 PGR (0.44) RORARORCRORBPGRKIF11
SCHEMBL26760307 0.83 KIF11 (0.41) RORARORCRORBPGRKIF11
SCHEMBL24822760 0.82 HTR1D (0.33) RORARORCRORBHTR1DPTGES2
SCHEMBL22178468 0.82 RORA (0.38) RORARORCRORBPGRKIF11
SCHEMBL25478624 0.81 HTR1D (0.42) RORARORCRORBPGRKIF11
SCHEMBL20857917 0.81 HTR1D (0.44) RORARORCRORBPGRKIF11
SCHEMBL20857875 0.81 HTR1D (0.44) RORARORCRORBPGRKIF11
SCHEMBL20858005 0.79 KIF11 (0.45) RORARORCRORBPGRKIF11
SCHEMBL24989248 0.79 DNMT1 (0.33) RORARORCRORBPGRDNMT1
SCHEMBL21127046 0.78 DNMT1 (0.36) RORARORCRORBPGRKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11569449-B2 Organic electroluminescence device and novel compound IDEMITSU KOSAN CO., LTD. (JP) 2023-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11569449-B2 Organic electroluminescence device and novel compound PIEZO1, TMEM109, OXA1L RORA 2765/4885RORC 3050/4885RORB 2815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.